Citation: H. Yoriyaz et al., Monte Carlo MCNP-4B-based absorbed dose distribution estimates for patient-specific dosimetry, J NUCL MED, 42(4), 2001, pp. 662-669
Citation: Mg. Stabin et al., Contribution to red marrow absorbed dose from total body activity: A correction to the MIRD method, J NUCL MED, 42(3), 2001, pp. 492-498
Citation: Mg. Stabin et al., Modeling radiation dose and effects from internal emitters in nuclear medicine: From the whole body to individual cells, CELL MOL B, 47(3), 2001, pp. 535-543
Citation: Re. Toohey et al., The AAPM/RSNA physics tutorial for residents - Internal radiation dosimetry: Principles and applications, RADIOGRAPHI, 20(2), 2000, pp. 533-546
Citation: Mg. Stabin et Hb. Breitz, Breast milk excretion of radiopharmaceuticals: Mechanisms, findings, and radiation dosimetry, J NUCL MED, 41(5), 2000, pp. 863-873
Citation: Mg. Stabin et Mw. Konijnenberg, Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes, J NUCL MED, 41(1), 2000, pp. 149-160
Authors:
Stabin, MG
Konijnenberg, M
Knapp, FF
Spencer, RH
Citation: Mg. Stabin et al., Monte Carlo modeling of radiation dose distributions in intravascular radiation therapy, MED PHYS, 27(5), 2000, pp. 1086-1092
Authors:
Traino, AC
Di Martino, F
Lazzeri, M
Stabin, MG
Citation: Ac. Traino et al., Influence of thyroid volume reduction on calculated dose in radioiodine therapy of Graves' hyperthyroidism, PHYS MED BI, 45(1), 2000, pp. 121-129
Authors:
Behr, TM
Sgouros, G
Stabin, MG
Behe, M
Angerstein, C
Blumenthal, RD
Apostolidis, C
Molinet, R
Sharkey, RM
Koch, L
Goldenberg, DM
Becker, W
Citation: Tm. Behr et al., Studies on the red marrow dosimetry in radioimmunotherapy: An experimentalinvestigation of factors influencing the radiation-induced myelotoxicity in therapy with beta-, Auger/conversion electron-, or alpha-emitters, CLIN CANC R, 5(10), 1999, pp. 3031S-3043S
Authors:
Cremonesi, M
Ferrari, M
Zoboli, S
Chinol, M
Stabin, MG
Orsi, F
Maecke, HR
Jermann, E
Robertson, C
Fiorenza, M
Tosi, G
Paganelli, G
Citation: M. Cremonesi et al., Biokinetics and dosimetry in patients administered with In-111-DOTA-Tyr(3)-octreotide: implications for internal radiotherapy with Y-90-DOTATOC, EUR J NUCL, 26(8), 1999, pp. 877-886
Authors:
Cremonesi, M
Ferrari, M
Chinol, M
Stabin, MG
Grana, C
Prisco, G
Robertson, C
Tosi, G
Paganelli, G
Citation: M. Cremonesi et al., Three-step radioimmunotherapy with yttrium-90 biotin: dosimetry and pharmacokinetics in cancer patients, EUR J NUCL, 26(2), 1999, pp. 110-120
Authors:
Thomas, SR
Stabin, MG
Chen, CT
Samaratunga, RC
Citation: Sr. Thomas et al., MIRD Pamphlet No. 14 revised: A dynamic urinary bladder model for radiation dose calculations, J NUCL MED, 40(4), 1999, pp. 102S-123S
Authors:
Siegel, JA
Thomas, SR
Stubbs, JB
Stabin, MG
Hays, MT
Koral, KF
Robertson, JS
Howell, RW
Wessels, BW
Fisher, DR
Weber, DA
Brill, AB
Citation: Ja. Siegel et al., MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates, J NUCL MED, 40(2), 1999, pp. 37S-61S
Authors:
Behr, TM
Behe, M
Stabin, MG
Wehrmann, E
Apostolidis, C
Molinet, R
Strutz, F
Fayyazi, A
Wieland, E
Gratz, S
Koch, L
Goldenberg, DM
Becker, W
Citation: Tm. Behr et al., High-linear energy transfer (LET) alpha versus low-LET beta emitters in radioimmunotherapy of solid tumors: Therapeutic efficacy and dose-limiting toxicity of Bi-213- versus Y-90-labeled CO17-1A Fab ' fragments in a human colonic cancer model, CANCER RES, 59(11), 1999, pp. 2635-2643